https://pmc.ncbi.nlm.nih.gov/articles/PMC9707418/
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early...
This review describes the research and development process of gantenerumab, a fully human anti-amyloid monoclonal antibody in development to treat early...
monoclonal antibodywith potentialin earlygantenerumabamyloid
https://dian.wustl.edu/gantenerumab-improved-markers-of-disease-in-rare-inherited-form-of-alzheimers-disease/
Gantenerumab improved markers of disease in rare, inherited form of Alzheimer’s disease |...
gantenerumabimprovedmarkersdiseaserare